Perrigo buys UK's Rosemont Pharma for $283 million
(Reuters) - Perrigo Co PRGO.O, a maker of generic and over-the-counter drugs, said it bought UK-based Rosemont Pharmaceuticals Ltd for about $283 million in cash to gain access to Rosemont's oral liquid formulations business.
The deal is expected to add 8 cents to Perrigo's adjusted earnings per share for the remainder of fiscal 2013, Perrigo said in a statement.
Perrigo had earlier forecast adjusted earnings of $5.45 to $5.65 per share.
Rosemont manufactures and supplies over 150 liquid medicines for joint disease, infections and gastrointestinal disorders.
Perrigo said Rosemont, which had net sales of more than $60 million in 2012, will become a part of its prescription drugs business.
The transaction comes 10 days after Perrigo bought privately held Velcera Inc for $160 million, its second acquisition in the animal healthcare market in four months.
It bought Sergeant's Pet Care Products for $285 million last September to tap into the animal healthcare market.
Shares of Perrigo were trading up about 2 percent at $110.13 in early trade on Monday on the Nasdaq.
(Reporting by Esha Dey and Vrinda Manocha in Bangalore; Editing by Roshni Menon)
FOX LAKE Ill. - The news about deadly crashes linked to a faulty ignition switch, followed by wave upon wave of recalls, did not bode well for General Motors dealers earlier this year. It conjured visions of worried, frustrated drivers pouring onto lots like Raymond Chevrolet, outside of Chicago.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.